{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:45Z","timestamp":1786119405517,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/wnf.0b013e3181c4ae2e","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:52:06Z","timestamp":1267062726000},"page":"11-13","source":"Crossref","is-referenced-by-count":13,"title":["Impulse Control Disorder and Piribedil"],"prefix":"10.1097","volume":"33","author":[{"given":"Lorena","family":"Tschopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulema","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco T.","family":"Gomez Botello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Uribe","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"12","key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/mds.21110","article-title":"Problematic gambling on dopamine agonists: not such a rarity.","volume":"21","author":"Grosset","year":"2006","journal-title":"Mov Disord"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson's disease.","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson Disease.","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","article-title":"Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.","volume":"68","author":"Tippmann-Peikert","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.22429","article-title":"Parkinsonism and impulse control disorder: presentation of a new progranulin gene mutation.","volume":"24","author":"Wong","year":"2009","journal-title":"Mov Disord"},{"issue":"3","key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10899-009-9123-2","article-title":"Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.","volume":"25","author":"Holman","year":"2009","journal-title":"J Gambl Stud"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease.","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease.","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopamine drug-related pathological gambling in Parkinson's disease.","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"R14-3-20210203","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.parkreldis.2006.01.010","article-title":"Hypersexuality and paraphilia induced by selegiline in Parkinson' s disease: report of 2 cases.","volume":"12","author":"Shapiro","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use.","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov Disord"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","article-title":"Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease.","volume":"65","author":"Evans","year":"2005","journal-title":"Neurology"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNN.0b013e31802b6c34","article-title":"Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling.","volume":"20","author":"Ferreira Garcia","year":"2007","journal-title":"Cogn Behav Neurol"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","article-title":"Prevalence of pathological gambling in patients with Parkinson's disease.","volume":"21","author":"Avanzi","year":"2006","journal-title":"Mov Disord"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.","volume":"19","author":"Evans","year":"2004","journal-title":"Mov Disord"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.parkreldis.2005.12.003","article-title":"Impaired decision-making in Parkinson's disease.","volume":"12","author":"Mimura","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.2005.065417","article-title":"Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's.","volume":"77","author":"Evans","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.parkreldis.2006.02.004","article-title":"Dopamine agonist therapy for Parkinson disease and pathological gambling.","volume":"12","author":"Imamura","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00023210-200822050-00004","article-title":"Antiparkinsonian medication and pathological gambling.","volume":"22","author":"Lader","year":"2008","journal-title":"CNS Drugs"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson' Disease.","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201001000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:10:05Z","timestamp":1786039805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201001000-00003"}},"subtitle":["Report of 5 Cases"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181c4ae2e","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}